Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 11 , Pages 781-788 , December 2009

Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults

  • S. Lee

      Affiliations

    • Center for Obesity, Nutrition and Metabolism, Department of Family Medicine, Pusan National University Hospital, 1-10 Ami-dong, Seo-gu, Busan 602 739, South Korea
    • Medical Education Unit, Pusan National University School of Medicine, Yangsan, 626 770, South Korea
    • Medical Research Institute, Pusan National University, Yangsan, 626 770, South Korea
    • Corresponding Author InformationCorresponding author. Department of Family Medicine, Pusan National University Hospital, 1-10 Ami-dong, Seo-gu, Busan 602 739, South Korea. Tel.: +82 51 240 7834; fax: +82 51 242 8671.
    • ,
  • H.K. Park

      Affiliations

    • Bnn clinic, Busan, 612 020, South Korea
    • ,
  • S.P. Son

      Affiliations

    • Department of Internal Medicine, Bongseng Memorial Hospital, Busan, 601 723, South Korea
    • ,
  • C.W. Lee

      Affiliations

    • Department of Internal Medicine, Busan St. Mary's Medical Center, Busan, 608 838, South Korea
    • ,
  • I.J. Kim

      Affiliations

    • Medical Research Institute, Pusan National University, Yangsan, 626 770, South Korea
    • Department of Internal Medicine, Pusan National University School of Medicine, Busan, 602 739, South Korea
    • ,
  • H.J. Kim

      Affiliations

    • Department of Physical Education, Pusan National University College of Education, Busan, 609 735, South Korea

Received 16 July 2008 ,Revised 16 December 2008 ,Accepted 9 January 2009.

References 

  1. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens. 1997;10:346–355
  2. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24:39–52
  3. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147–1152
  4. de Valk HW, Verkaaik R, van Rijn HJ, Geerdink RA, Struyvenberg A. Oral magnesium supplementation in insulin-requiring type 2 diabetic patients. Diabet Med. 1998;15:503–507
  5. Lopez-Ridaura R, Willett WC, Rimm EB, Liu S, Stampfer MJ, Manson JE, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:134–140
  6. van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR. Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S black women. Diabetes Care. 2006;29:2238–2243
  7. Touyz RM. Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med. 2003;24:107–136
  8. Song Y, Sesso HD, Manson JE, Cook NR, Buring JE, Liu S. Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. Am J Cardiol. 2006;98:1616–1621
  9. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension. 1998;32:260–265
  10. Jee SH, Miller ER, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002;15:691–696
  11. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens. 2006;24:215–233
  12. Kim DM, Ahn CW, Nam SY. Prevalence of obesity in Korea. Obes Rev. 2005;6:117–121
  13. Steering Committee of the WHO Western Pacific Region, IASO & IOTF . The Asia–Pacific perspective: redefining obesity and its treatment. Melbourne: Australia Pty Ltd; 2000;pp. 8–56
  14. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–1124
  15. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395
  16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  17. Rodushkin I, Axelsson MD. Application of double focusing sector field ICP-MS for multielemental characterization of human hair and nails. Part I. Analytical methodology. Sci Total Environ. 2000;250:83–100
  18. Cappuccio FP, Markandu MD, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: a double blind study. BMJ. 1985;291:235–258
  19. Wälti MK, Zimmermann MB, Spinas GA, Hurrell RF. Low plasma magnesium in type 2 diabetes. Swiss Med Wkly. 2003;133:289–292
  20. Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: a meta-analysis. J Intern Med. 2007;262:208–214
  21. Guerrero-Romero F, Rodríguez-Morán M. Complementary therapies for diabetes: the case for chromium, magnesium, and antioxidants. Arch Med Res. 2005;36:250–257
  22. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004;30:253–258
  23. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006;23:1050–1056
  24. Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ. Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol. 2006;164:449–458
  25. Wang JL, Shaw NS, Yeh HY, Kao MD. Magnesium status and association with diabetes in the Taiwanese elderly. Asia Pac J Clin Nutr. 2005;14:263–269
  26. Fruhwald FM, Dusleag J, Fruhwald SM, Grisold M, Gasser R, Klein W. A physiological oral magnesium supplement does not influence total serum magnesium, left ventricular ejection fraction and prognosis in patients with dilated cardiomyopathy. Magnes Res. 1993;6:251–255
  27. Dimai HP, Porta S, Wirnsberger G, Lindschinger M, Pamperl I, Dobnig H, et al. Daily oral magnesium supplementation suppresses bone turnover in young adult males. J Clin Endocrinol Metab. 1998;83:2742–2748
  28. Meisel P, Schwahn C, Luedemann J, John U, Kroemer HK, Kocher T. Magnesium deficiency is associated with periodontal disease. J Dent Res. 2005;84:937–941
  29. Vormann J. Magnesium: nutrition and metabolism. Mol Aspects Med. 2003;24:27–37
  30. Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994;13:416–423
  31. Oh SW, Yoon YS, Lee ES, Kim WK, Park C, Lee S, et al. Association between cigarette smoking and metabolic syndrome: the Korea National Health and Nutrition Examination Survey. Diabetes Care. 2005;28:2064–2066
  32. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol. 2005;105:402–410
  33. Dickinson HO, Nicolson DJ, Campbell F, Cook JV, Beyer FR, Ford GA, et al. Magnesium supplementation for the management of essential hypertension in adults. Cochrane Database Syst Rev. 2006;3:CD004640
  34. Itoh K, Kawasaka T, Nakamura M. The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects. Br J Nutr. 1997;78(5):737–750
  35. Yamamoto ME, Applegate WB, Klag MJ, Borhani NO, Cohen JD, Kirchner KA, et al. Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from phase I of the trials of hypertension prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group Ann Epidemiol. 1995;5:96–107
  36. Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M, et al. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab. 2004;89:1481–1484
  37. Lee S, Choi S, Kim HJ, Chung YS, Lee KW, Lee HC, et al. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci. 2006;21:695–700
  38. Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus and its complications: part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med. 1998;15:539–553

PII: S0939-4753(09)00010-6

doi: 10.1016/j.numecd.2009.01.002

Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 11 , Pages 781-788 , December 2009

Article Tools

* Image Usage & Resolution